Similar articles for PMID: 23821689

Year	Number of Results
1965	1
1980	1
1991	1
2007	1
2008	1
2009	2
2010	6
2011	14
2012	46
2013	83
2014	76
2015	35
2016	11
2017	8
2018	7
2019	2
2020	1
2021	2
2022	0

1

Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.

Fawole A, Daw HA, Crowther MA. Fawole A, et al. Cleve Clin J Med. 2013 Jul;80(7):443-51. doi: 10.3949/ccjm.80a.13025. Cleve Clin J Med. 2013. PMID: 23821689 Free article. Review.

2

Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.

[No authors listed] [No authors listed] Prescrire Int. 2013 Jun;22(139):155-9. Prescrire Int. 2013. PMID: 23866358 Review.

3

[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].

Oberhofer E. Oberhofer E. MMW Fortschr Med. 2015 Jan 19;157(1):24. doi: 10.1007/s15006-015-2575-7. MMW Fortschr Med. 2015. PMID: 25743289 German. No abstract available.

4

New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.

Tran H, Joseph J, Young L, McRae S, Curnow J, Nandurkar H, Wood P, McLintock C. Tran H, et al. Intern Med J. 2014 Jun;44(6):525-36. doi: 10.1111/imj.12448. Intern Med J. 2014. PMID: 24946813

5

[Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].

Nagler M, Wuillemin W. Nagler M, et al. Ther Umsch. 2012 Nov;69(11):650-6. doi: 10.1024/0040-5930/a000343. Ther Umsch. 2012. PMID: 23117668 Review. German.

6

The new oral anticoagulants in clinical practice.

Gonsalves WI, Pruthi RK, Patnaik MM. Gonsalves WI, et al. Mayo Clin Proc. 2013 May;88(5):495-511. doi: 10.1016/j.mayocp.2013.03.006. Mayo Clin Proc. 2013. PMID: 23639500 Review.

7

Management of hemorrhage with the target-specific oral anticoagulants.

Pluym M, Howell G. Pluym M, et al. Hosp Pract (1995). 2014 Aug;42(3):75-83. doi: 10.3810/hp.2014.08.1120. Hosp Pract (1995). 2014. PMID: 25255409 Review.

8

Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.

Gong IY, Kim RB. Gong IY, et al. Can J Cardiol. 2013 Jul;29(7 Suppl):S24-33. doi: 10.1016/j.cjca.2013.04.002. Can J Cardiol. 2013. PMID: 23790595 Review.

9

New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.

Fenger-Eriksen C, Münster AM, Grove EL. Fenger-Eriksen C, et al. Acta Anaesthesiol Scand. 2014 Jul;58(6):651-9. doi: 10.1111/aas.12319. Epub 2014 Apr 9. Acta Anaesthesiol Scand. 2014. PMID: 24716468 Review.

10

[General characteristics of the new oral anticoagulants].

Gegu M, Chevalet P, Piloquet FX, Berrut G, De Decker L. Gegu M, et al. Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(1 Suppl):4-9. doi: 10.1684/pnv.2013.0446. Geriatr Psychol Neuropsychiatr Vieil. 2013. PMID: 24463058 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed